Press release
mRNA Synthesis and Manufacturing Services Market Drivers Increasing Demand for Infectious Disease Vaccines and Therapeutic Applications
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global mRNA Synthesis and Manufacturing Services Market (by Type of Industry (Therapeutics and Vaccine Developers, CDMO Organizations, Custom Synthesis/Other Service Providers), Applications (Infectious Disease Vaccines, Other Vaccines, Therapeutics and Others), Scale of Operation (Research / Preclinical, Clinical, Commercial))- Market Outlook and Industry Analysis 2034"Global mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.52 Mn in 2024 and is predicted to reach USD 2,294.90 Mn by the year 2034 at a 7.7% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1185
Messenger RNA (mRNA) molecules are single-stranded nucleic acids transcribed from DNA that play a pivotal role in gene expression by directing the synthesis of specific proteins within cells. Owing to their intrinsic versatility and adaptability, mRNA platforms have emerged as a robust foundation for the development of therapeutic and prophylactic vaccines addressing a broad range of infectious and chronic diseases. Relative to traditional pharmaceuticals, mRNA vaccines offer improved immunogenicity, higher success rates, and cost-efficient manufacturing processes. The global rollout of mRNA-based COVID-19 vaccines, followed by approvals for additional viral pathogens, has significantly accelerated demand for mRNA manufacturing capabilities.
Beyond vaccine development, mRNA therapeutics demonstrate considerable potential in treating complex conditions such as infectious diseases, metabolic genetic disorders, oncology indications, cardiovascular, and cerebrovascular diseases. These therapies carry no risk of unintended infection or insertional mutagenesis, offering a distinct advantage over conventional gene therapies. Moreover, mRNA enables sustained protein expression through continuous translation, resulting in superior therapeutic efficacy compared with traditional protein- or peptide-based drugs.
The growth of the mRNA synthesis and manufacturing services sector is primarily driven by the increasing prevalence of rare diseases, including propionic acidemia, methylmalonic acidemia, glycogen storage disorders, and, as well as metabolic and immunological disorders. Rising incidences of chronic conditions such as cancer, cardiovascular disease, pulmonary disorders, and chronic kidney disease are further augmenting market demand. Advances in biopharmaceutical production technologies have prompted service providers to expand manufacturing capacity and infrastructure to accommodate the increasing requirements of this innovative therapeutic class.
Market expansion is also supported by the growing number of clinical trials targeting oncology and infectious diseases. Industry trends indicate elevated investment activity, strategic partnerships, mergers, and intensified research and development initiatives. For instance, in April 2021, Arcturus Therapeutics, a U.S.-based mRNA company, formed a joint venture with Axcelead, Inc. in Japan, establishing a new entity in Chiba Prefecture and initiating construction of a manufacturing facility in Minamisoma City, Fukushima Prefecture. Such strategic initiatives are expected to substantially enhance sector growth and market adoption over the coming years.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
The expansion of mRNA synthesis and manufacturing services is, however, being hampered by a dearth of manufacturing procedures that are flexible, sustainable, and efficient in terms of cost. Also, the lengthy process of approvals and long-term clinical trials will hamper the market growth in the forecasting period.
The mRNA synthesis and manufacturing services market in North America will be driven by the availability of significant financing for research, the expansion of federal programmes toward RNA-based therapeutics, and the increasing number of clinical studies.
Some of the significant market players in the mRNA synthesis and manufacturing services market are eTheRNA (Etherna Immunotherapies), Eurogentec, Aldevron, biosynthesis, Biomay, Jena Biosciences, APExBIO, TriLink BioTechnologies, CELLSCRIPT, Thermo Fisher Scientific, New England Biolabs, BioNTech (Pfizer), Translate Bio, CureVac, Moderna, Ethris (AstraZeneca), Kernal Biologics, Silence Therapeutics, In-Cell-Art, Anima Biotch, H3 Biomedicine Inc., Tiba Biotechnology, Arcturus Therapeutics, Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., eFFECTOR Therapeutics, Inc., Ziphius Therapeutics NV, miRagen Therapeutics, Inc., RNAimmune (Sirnaomics), Skyhawk Therapeutics, Inc, Strand Therapeutics Inc., and other Prominent Players.
Key Developments in the Market :
• In Aug 2022, A novel enzymatic mRNA capping solution for the manufacture of mRNA was introduced by New England Biolabs® under the name Faustovirus Capping Enzyme. This new enzyme boosts the capping effectiveness and scalability for mRNA manufacturing workflows, including vaccine production.
• In Jan 2022, Pfizer and BioNTech signed a new global collaboration agreement to work together on developing the first mRNA-based shingles vaccine. Both Pfizer's antigen technology and BioNTech's proprietary mRNA technology will be utilised to develop potential product candidates. It is expected that clinical trials will begin in the second half of the year 2022.
• In Oct 2021, Silence Therapeutics and Hansoh Pharma announced a collaboration to develop therapeutics utilising Silence's mRNAi GOLDTM Platform. The upfront cash payment from Hansoh is expected to be sixteen million dollars, and the possible milestone payments for Silence might be as high as one billion three hundred million dollars.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1185
Market Segmentation:
Global mRNA Synthesis and Manufacturing Services Market, by Type of Industry 2022-2030 (Value US$ Mn)
• Therapeutics and Vaccine Developers
• CDMO Organizations
• Custom Synthesis/Other Service Providers
Global mRNA Synthesis and Manufacturing Services Market, by Applications, 2022-2030 (Value US$ Mn)
• Infectious Disease Vaccines
• Other Vaccines
• Therapeutics and Others
Global mRNA Synthesis and Manufacturing Services Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Research / Preclinical
• Clinical
• Commercial
Global mRNA Synthesis and Manufacturing Services Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global mRNA Synthesis and Manufacturing Services Market
To receive an industry overview and future trends of the mRNA Synthesis and Manufacturing Services Market
To analyze mRNA Synthesis and Manufacturing Services Market drivers and challenges
To get information on the mRNA Synthesis and Manufacturing Services Market size (Value US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the mRNA Synthesis and Manufacturing Services Market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-mrna-synthesis-and-manufacturing-services-market/1185
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Synthesis and Manufacturing Services Market Drivers Increasing Demand for Infectious Disease Vaccines and Therapeutic Applications here
News-ID: 4261118 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Isothermal Nucleic Acid Amplification Technology Market Analysis Competitive Lan …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Isothermal Nucleic Acid Amplification Technology Market - (By Product (Assays, Kits & Reagents, Systems), By Application (Disease Diagnosis (Hepatitis, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Influenza, Covid-19, Other Disease Diagnosis), Blood Screening, Other Applications), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA), Nucleic Acid Sequence-based Amplification…
NAD-based Anti-Aging Market Growth Drivers Rising Geriatric Population and Incre …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores) Trends, Industry Competition Analysis,…
Regenerative Aesthetics Exosome Products Market Opportunities in Dermatology Cli …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Regenerative Aesthetics Exosome Products Market- (Application (Skin Rejuvenation, Hair Restoration, Scar Reduction and Wound Healing, Anti-Inflammatory Treatments), End User (Aesthetic Clinics, Home Use, Dermatology Clinics)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Regenerative Aesthetics Exosome Products Market is expected to grow with…
Pharma Contract Commercialization (CCO) Market Opportunities in Pharma MedTech H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Contract Commercialization (CCO) Market Size, Share & Trends Analysis Report By services (Strategic Consulting, Market Access (Including RWE and HEOR), Pricing & Reimbursement, Medical Affairs, Regulatory & Compliance ), business model (Tech/Data Enabled and/or Subscription Model and Consulting Model) and end user (Pharma, MedTech, Healthcare Providers, Payers ), Region, Market Outlook And Industry…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
